Home/Pipeline/Latuda (lurasidone)

Latuda (lurasidone)

Schizophrenia, Bipolar Depression

ApprovedActive

Key Facts

Indication
Schizophrenia, Bipolar Depression
Phase
Approved
Status
Active
Companies

About Angelini Pharma

Angelini Pharma is a century-old, private Italian pharmaceutical company with a significant international commercial footprint across Europe and the United States. Its strategy is built on a diversified portfolio spanning prescription drugs in Brain Health, Specialty Care, and over-the-counter Consumer Healthcare products. The company demonstrates a clear commitment to its core therapeutic areas through ongoing commercial initiatives, medical education platforms like Headway, and a pipeline that includes recently launched CNS products such as Ontozry.

View full company profile

About Sumitomo Dainippon Pharma

A Japanese pharmaceutical company developing innovative therapies in neuroscience, oncology, and regenerative medicine, with a focus on small molecules and iPS cell-derived cell therapies.

View full company profile

Other Schizophrenia, Bipolar Depression Drugs

DrugCompanyPhase
CAPLYTA (lumateperone)Intra-Cellular TherapiesApproved